Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Monoamine oxidases -nicotine

Villegier, A.S., Blanc, G., Glowinski, J., Tassin, J.P. Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol. Biochem. Behav. 76 267, 2003. [Pg.49]

Increased bilirubin levels are caused due to the intake of large doses of such drugs as chloroquine, vitamin K, sulpha-drugs, tetracyclines, paracetamol, nicotinic acid and monoamine oxidase inhibitors (e.g., iproniazid RP 1.0 nialamide RP 1.8 isocarboxazid RP 3.1 phenelzine RP 18 pheniprazine RP31 and tranylcypromine RP 45), where RP designates the Relative Potency based on the tiyptamine potentiation test. The elevated levels are due to hepatic injury, and... [Pg.57]

Benwell ME, Balfour DJK, Anderson JM (1988) Evidence that tobacco smoking increases the density of (-)-[ H]nicotine binding sites in human brain. J Neurochem 50 1243-1247 Berlin 1, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. Int J Neuropsy-chopharmacol 4 33 2... [Pg.162]

Villegier AS, Salomon L, et al (2006) Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31(8) 1704-1713 von Ziegler NI, Schlumpf M, et al (1991) Prenatal nicotine exposure selectively affects perinatal forebrain aromatase activity and fetal adrenal function in male rats. Brain Res Dev Brain Res 62(1) 23-31... [Pg.294]

Wiley JL, LaVecchia KL, Martin BR, Damaj MI (2002) Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol 10 129-135 Williams M, Robinson JL (1984) Binding of the nicotinic cholinergic antagonist, dihydro-beta-erythroidine, to rat brain tissue. J Neurosci 4 2906-2911 Witkin JM, Dykstra LA, Carter RB (1982) Acute tolerance to the discriminative stimulus properties of morphine. Pharmacol Biochem Behav 17 223-228 Wooters TE, Bardo MT (2007) The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behav Pharmacol 18 601-608 Wright JM Jr, Vann RE, Gamage TE, Damaj MI, WUey JL (2006) Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats. Pharmacol Biochem Behav 85 507-513... [Pg.332]

Agatsuma S, Lee M, Zhu H, Chen K, Shih 1C, Seif I, Hiroi N (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol Genet 15 2721-2731... [Pg.357]

Guillem K, VouiUac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neu-rosci 25 8593-8600... [Pg.360]

Nicotine, 4 phenylpyridine, and hydrazine, administered to mice, prevented the decrease in dopamine metabolite levels induced by MPTP, but there was no significant effect on dopamine levels. The compounds did not inhibit monoamine oxidase (MAO) activity in cerebral tissue in vivo. In vitro, an extract produced significant inhibition of MAO A and B activities in the... [Pg.306]

Substances in smoke other than nicotine may also affect the brain. An unknown substance in smoke causes a decrease in the level of monoamine oxidase (MAO), an important enzyme responsible for breaking down dopamine. The decrease in MAO results in higher dopamine levels, which contributes to the desire to keep smoking. [Pg.371]

To inhibit Aj8 aggregation into amyloid is to prevent misfolding of soluble AjS. Once the misfoldingtook place the aggregation is only a matter of time and far more difficult to control (174). So far only nicotine (30,Fig. 13.9) and melatonin (31)appear to be affecting the conformation of soluble AjS (175-177). Antioxidants, such as antituberculosis antibiotic ri-fampicin (32) or a-tocopherol, were reported to inhibit aggregation and neurotoxicity of AjS in vitro (178-180). A monoamine oxidase inhibitor, selegiline (33, Fig. 13.9), may also be... [Pg.758]

Acetylcholinesterase inhibitors Alzheimer s disease caffeine cholinergic dopaminergic monoamine oxidase muscarinic receptor nicotinic receptor Parkinson s disease Vinca... [Pg.1332]

Rose JE, Behm FM, Ramsey C, Ritchie JRJC. Platelet monoamine oxidase, smoking cessation and tobacco withdrawal symptoms. Nicotine and Tobacco Res. 2001 3(4) 383-390. [Pg.657]

See other pages where Monoamine oxidases -nicotine is mentioned: [Pg.228]    [Pg.334]    [Pg.42]    [Pg.45]    [Pg.449]    [Pg.44]    [Pg.122]    [Pg.140]    [Pg.146]    [Pg.160]    [Pg.165]    [Pg.210]    [Pg.230]    [Pg.346]    [Pg.350]    [Pg.357]    [Pg.359]    [Pg.506]    [Pg.1421]    [Pg.581]    [Pg.197]    [Pg.198]    [Pg.26]    [Pg.1030]    [Pg.721]    [Pg.482]    [Pg.332]    [Pg.4]    [Pg.1481]    [Pg.268]    [Pg.1059]   
See also in sourсe #XX -- [ Pg.43 ]



SEARCH



Monoamine oxidase

Nicotine monoamine oxidase activity

Nicotine oxidase

Oxidases monoamine oxidase

© 2024 chempedia.info